- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.8 | 2.11 |
NAV | ₹517.09 | ₹30.16 |
Fund Started | 10 May 2004 | 04 Dec 2015 |
Fund Size | ₹8352.16 Cr | ₹1231.67 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.25% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
3.0
3.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.8
2.11
NAV
₹517.09
₹30.16
Fund Started
10 May 2004
04 Dec 2015
Fund Size
₹8352.16 Cr
₹1231.67 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.25% if redeemed within 30 days.
Returns
1 Year | 15.72% | 14.65% |
3 Year | 25.23% | 24.71% |
5 Year | 22.27% | 22.05% |
1 Year
15.72%
14.65%
3 Year
25.23%
24.71%
5 Year
22.27%
22.05%
Holding Analysis
Equity | 98.60% | 90.83% |
Cash | 1.40% | 9.17% |
Equity
98.60%
90.83%
Cash
1.40%
9.17%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.57% |
Divi's Laboratories Ltd. | 9.49% |
Lupin Ltd. | 5.82% |
Cipla Ltd. | 5.62% |
Dr. Reddy's Laboratories Ltd. | 5.49% |
Apollo Hospitals Enterprise Ltd. | 5.34% |
Medplus Health Services Ltd. | 4.20% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.73% |
Vijaya Diagnostic Centre Ltd. | 3.24% |
Narayana Hrudayalaya Ltd. | 2.94% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.64% |
Apollo Hospitals Enterprise Ltd. | 6.22% |
Cipla Ltd. | 5.83% |
Aurobindo Pharma Ltd. | 5.73% |
Divi's Laboratories Ltd. | 5.63% |
Fortis Healthcare Ltd. | 4.90% |
Lupin Ltd. | 4.82% |
Aster DM Healthcare Ltd. | 4.35% |
Wockhardt Ltd. | 3.27% |
Dr. Reddy's Laboratories Ltd. | 3.16% |
Fund Manager
Name | Akshay Sharma | Meeta Shetty |
Start Date | 01 Dec 2022 | 27 Jan 2025 |
Name
Akshay Sharma
Meeta Shetty
Start Date
01 Dec 2022
27 Jan 2025
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. |
Launch Date | 10 May 2004 | 04 Dec 2015 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
10 May 2004
04 Dec 2015